Liver Resection for Bismuth Type I and Type II Hilar Cholangiocarcinoma
Jin Hong Lim
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorCorresponding Author
Gi Hong Choi
- [email protected]
- +82-2-2228-2100 | Fax: +82-2-313-8289
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Tel.: +82-2-2228-2100, Fax: +82-2-313-8289, [email protected]Search for more papers by this authorSung Hoon Choi
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorKyung Sik Kim
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorJin Sub Choi
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorWoo Jung Lee
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorJin Hong Lim
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorCorresponding Author
Gi Hong Choi
- [email protected]
- +82-2-2228-2100 | Fax: +82-2-313-8289
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Tel.: +82-2-2228-2100, Fax: +82-2-313-8289, [email protected]Search for more papers by this authorSung Hoon Choi
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorKyung Sik Kim
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorJin Sub Choi
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorWoo Jung Lee
Department of Surgery, Yonsei University College of Medicine, 134, Sinchon-dong, Seodaemum-gu, 120-75 Seoul, Korea
Search for more papers by this authorAbstract
Background
In patients with Bismuth type I and II hilar cholangiocarcinoma (HCCA), bile duct resection alone has been the conventional approach. However, many authors have reported that concomitant liver resection improved surgical outcomes.
Methods
Between January 2000 and January 2012, 52 patients underwent surgical resection for a Bismuth type I and II HCCA (type I: n = 22; type II: n = 30). Patients were classified into two groups: concomitant liver resection (n = 26) and bile duct resection alone (n = 26).
Results
Bile duct resection alone was performed in 26 patients. Concomitant liver resection was performed in 26 patients (right side hepatectomy [n = 13]; left-side hepatectomy [n = 6]; volume-preserving liver resection [n = 7]). All liver resections included a caudate lobectomy. Patient and tumor characteristics did not differ between the two groups. Although concomitant liver resection required longer operating time (P < 0.001), it had a similar postoperative complication rate (P = 0.764), high curability (P = 0.010), and low local recurrence rate (P = 0.006). Concomitant liver resection showed better overall survival (P = 0.047).
Conclusions
Concomitant liver resection should be considered in patients with Bismuth type I and II HCCA.
References
- 1KlatskinG Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatic. An unusual tumor with distinctive clinical and pathological features. Am J Med (1965) 38: 241–2561425672010.1016/0002-9343(65)90178-6
- 2NanashimaA, TobinagaS, AboT et al. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute. Hepatogastroenterology (2012) 59: 347–35022353497
- 3CannonRM, BrockG, BuellJF Surgical resection for hilar cholangiocarcinoma: experience improves respectability. HPB (Oxf) (2012) 14: 142–14910.1111/j.1477-2574.2011.00419.x
- 4SaxenaA, ChuaTC, ChuFC et al. Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival. Am J Surg (2011) 202: 310–3202187198610.1016/j.amjsurg.2010.08.041
- 5ItoF, ChoCS, RikkersLF et al. Hilar cholangiocarcinoma: current management. Ann Surg (2009) 250: 210–2181963892010.1097/SLA.0b013e3181afe0ab
- 6RuysAT, van HaelstS, BuschOR et al. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg (2012) 36: 2179–21862256974610.1007/s00268-012-1638-5
- 7NakeebA, PittHA, SohnTA et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 224: 463–473885785110.1097/00000658-199610000-00005discussion 473–475
- 8MiyazakiM, ItoH, NakagawaK et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection?. Surgery (1998) 123: 131–136948139710.1016/S0039-6060(98)70249-1
- 9YoungAL, IgamiT, SendaY et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 13: 483–49310.1111/j.1477-2574.2011.00328.x
- 10NaginoM, KamiyaJ, NishioH et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 243: 364–3721649570210.1097/01.sla.0000201482.11876.14
- 11MiyazakiM, KimuraF, ShimizuH et al. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. J Hepatobiliary Pancreat Surg (2007) 14: 463–4681790971410.1007/s00534-006-1195-0
- 12IgamiT, NishioH, EbataT et al. Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepato-biliary-pancreatic Sci (2010) 17: 449–45410.1007/s00534-009-0209-0
- 13KonstadoulakisMM, RoayaieS, GomatosIP et al. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg (2008) 196: 160–1691846686210.1016/j.amjsurg.2007.07.033
- 14KondoS, HiranoS, AmboY et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 240: 95–1011521362410.1097/01.sla.0000129491.43855.6b
- 15JarnaginWR, FongY, DeMatteoRP et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 234: 507–5171157304410.1097/00000658-200110000-00010discussion 517–509
- 16DinantS, GerhardsMF, RauwsEA et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol (2006) 13: 872–8801661487610.1245/ASO.2006.05.053
- 17ItoF, AgniR, RettammelRJ et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg (2008) 248: 273–2791865063810.1097/SLA.0b013e31817f2bfd
- 18DeOliveiraML, CunninghamSC, CameronJL et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 245: 755–7621745716810.1097/01.sla.0000251366.62632.d3
- 19KowAW, WookCD, SongSC et al. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution. World J Surg (2012) 36: 1112–11212237454110.1007/s00268-012-1497-0
- 20LaunoisB, TerblancheJ, LakehalM et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg (1999) 230: 266–2751045074210.1097/00000658-199908000-00018
- 21IkeyamaT, NaginoM, OdaK et al. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg (2007) 246: 1052–10571804311010.1097/SLA.0b013e318142d97e
- 22OtaniK, ChijiiwaK, KaiM et al. Role of hilar resection in the treatment of hilar cholangiocarcinoma. Hepatogastroenterology (2012) 59: 696–70022469711
- 23BismuthH, CorletteMB Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 140: 170–1781079096
- 24ClavienPA, BarkunJ, de OliveiraML et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 250: 187–1961963891210.1097/SLA.0b013e3181b13ca2
- 25KawasakiS, ImamuraH, KobayashiA et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 238: 84–9212832969
- 26JonasS, BenckertC, ThelenA et al. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol (2008) 34: 263–2711804249710.1016/j.ejso.2007.09.024
- 27NeuhausP, JonasS, SettmacherU et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg (2003) 388: 194–2001281997010.1007/s00423-003-0383-5
- 28FargesO, BelghitiJ, KianmaneshR et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 237: 208–21712560779
- 29AbdallaEK, DenysA, ChevalierP et al. Total and segmental liver volume variations: implications for liver surgery. Surgery (2004) 135: 404–4101504196410.1016/j.surg.2003.08.024
- 30TongyooA, PomfretEA, PomposelliJJ Accurate estimation of living donor right hemi-liver volume from portal vein diameter measurement and standard liver volume calculation. Am J Transplant (2012) 12: 1229–12392222180310.1111/j.1600-6143.2011.03909.x
- 31ShimizuH, KimuraF, YoshidomeH et al. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg (2010) 251: 281–2862005427510.1097/SLA.0b013e3181be0085
- 32MiyazakiM, ItoH, NakagawaK et al. Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma. Am J Surg (1998) 175: 229–231956012610.1016/S0002-9610(97)00295-X
- 33KawaradaY, IsajiS, TaokaH et al. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract. J Gastrointest Surg (1999) 3: 369–3731048268810.1016/S1091-255X(99)80052-3
- 34ShimadaH, NiimotoS, MatsubaA et al. The infiltration of bile duct carcinoma along the bile duct wall. Int Surg (1988) 73: 87–902840410
- 35SeyamaY, KubotaK, SanoK et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 238: 73–8312832968
- 36ShinguY, EbataT, NishioH et al. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery (2010) 147: 49–561976704810.1016/j.surg.2009.06.030
- 37BosmaA Surgical pathology of cholangiocarcinoma of the liver hilus (Klatskin tumor). Semin Liver Dis (1990) 10: 85–90216256910.1055/s-2008-1040460
- 38SakamotoE, NimuraY, HayakawaN et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg (1998) 227: 405–411952706410.1097/00000658-199803000-00013
- 39HayashiS, MiyazakiM, KondoY et al. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer (1994) 73: 2922–2929819998910.1002/1097-0142(19940615)73:12<2922::AID-CNCR2820731208>3.0.CO;2-K
10.1002/1097-0142(19940615)73:12<2922::AID-CNCR2820731208>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
